Citation Impact
Citing Papers
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Cancer statistics, 2022
2022 Standout
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect
2012
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
2016
Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors
2015
Cancer statistics, 2020
2020 Standout
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
2016
EGFR Antagonists in Cancer Treatment
2008 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Human papillomavirus and cervical cancer
2013
A novel mucosal orthotopic murine model of human papillomavirus‐associated genital cancers
2010
The epidemiology of human papillomavirus infections
2005
Cancer Prevention With Natural Compounds
2010
Risk of cancer in persons with AIDS in Italy, 1985–1998
2003
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Short-term and long-term effects of caesarean section on the health of women and children
2018 Standout
Trends in Squamous Cell Carcinoma of the Vulva: The Influence of Vulvar Intraepithelial Neoplasia
1997
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Cancer statistics, 2013
2013 Standout
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection
2007
Drivers of poor medical care
2017
Dynamic Education of Macrophages in Different Areas of Human Tumors
2012
Classification of papillomaviruses
2004 StandoutNobel
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Head and neck cancer
2008 Standout
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
2000
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy
2012
Psoriasis
2021 Standout
Chemoimmunotherapy: reengineering tumor immunity
2013
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Adoptive immunotherapy for cancer: harnessing the T cell response
2012
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Global cancer statistics
2011 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
2013
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia
2003
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
2012
Human papillomavirus and cervical cancer
2007 Standout
Chapter 2: The burden of HPV-related cancers
2006
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Combined human papillomavirus DNA and human papillomavirus‐like particle serologic assay to identify women at risk for high‐grade cervical intraepithelial neoplasia
2006
Cancer statistics, 2012
2012 Standout
DNA vaccines for HIV: challenges and opportunities
2006
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Chapter 9: Role of Mucosal Human Papillomavirus in Nongenital Cancers
2003
Vaccines and the Future of Human Immunology
2010
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
2010
Papillomavirus and HPV typing
1997
IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
2012
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus–Positive Women
2005
p53Mutations and Presence of HPV DNA Do Not Correlate with Radiosensitivity of Gynecological Cancer Cell Lines
1998
Clinician-Patient Risk Discussion for Atherosclerotic Cardiovascular Disease Prevention
2015
Molecular Epidemiology of Human Papillomavirus
2008
Bacterial magnetic particles as a novel and efficient gene vaccine delivery system
2011
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
2012
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Therapeutic Vaccination for HPV Induced Cervical Cancers
2007
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III
2007
Electroporation-enhanced delivery of nucleic acid vaccines
2014
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Vaccine strategies for human papillomavirus-associated cancers
2005
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Cervical cancer
2019 Standout
Head and Neck Cancer
2001 Standout
Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?
1999
New Approaches to Immunotherapy for HPV Associated Cancers
2011
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
2017
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
2016
Human papillomavirus–associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers
2001
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
2001
Resident memory T cells in human health and disease
2015
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Surgery followed by Persistence of High-Grade Squamous Intraepithelial Lesions Is Associated with the Induction of a Dysfunctional HPV16-Specific T-Cell Response
2008
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Human Papillomavirus and Cervical Cancer
2003 Standout
Cancer statistics, 2016
2016 Standout
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Cancer statistics, 2015
2015 Standout
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
IRF4 at the crossroads of effector T‐cell fate decision
2014
Cancer statistics, 2014
2014 Standout
HIV VACCINES
2005
Global cancer statistics, 2012
2015 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Molecular and Pathologic Aspects of Endometrial Carcinogenesis
2006
Works of Cornelia L. Trimble being referenced
Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell–Mediated Tumor Control in the Genital Tract
2015
Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
2014
Epigallocatechin-3-Gallate Enhances CD8+ T Cell–Mediated Antitumor Immunity Induced by DNA Vaccination
2007
HLA-DQB1*02–Restricted HPV-16 E7 Peptide–Specific CD4+ T-Cell Immune Responses Correlate with Regression of HPV-16–Associated High-Grade Squamous Intraepithelial Lesions
2007
Human Papillomavirus 16-Associated Cervical Intraepithelial Neoplasia in Humans Excludes CD8 T Cells from Dysplastic Epithelium
2010
Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity
2009
Heterogeneous Etiology of Squamous Carcinoma of the Vulva
1996
Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype
2005
Development of therapeutic HPV vaccines
2009
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts
2008
Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies
2005
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2/3 (CIN2/3)
2015
Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe
2003
Human Papillomavirus-Specific Serologic Response in Vulvar Neoplasia
1996
Cervical Neoplasia and Repeated Positivity of Human Papillomavirus Infection In Human Immunodeficiency Virus-seropositive and -seronegative Women
2000
Reproducibility of the diagnosis of atypical endometrial hyperplasia
2006
Stop the silent misdiagnosis: patients' preferences matter
2012
Human papillomavirus and the pathogenesis of vulvar carcinoma
1992
Cervical Cancer Screening
2010
DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial
2014
Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
2014
A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
2008
Development of a DNA Vaccine Targeting Human Papillomavirus Type 16 Oncoprotein E6
2004
Pretreatment with Cisplatin Enhances E7-Specific CD8+ T-Cell–Mediated Antitumor Immunity Induced by DNA Vaccination
2008